Effectiveness and tolerability of zafirlukast for the treatment of asthma in children

This publication has 15 references indexed in Scilit:

• An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses
  Published by Elsevier ,1999
• Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction
  Journal of Allergy and Clinical Immunology, 1998
• Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind Trial
  Archives of internal medicine (1960), 1998
• Montelukast for Chronic Asthma in 6- to 14-Year-Old Children
  JAMA, 1998
• Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study
  Clinical Therapeutics, 1997
• Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial
  Journal of Allergy and Clinical Immunology, 1996
• Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents
  Archives of internal medicine (1960), 1996
• Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group
  Published by American Medical Association (AMA) ,1996
• Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
  American Journal of Respiratory and Critical Care Medicine, 1994
• The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist
  American Review of Respiratory Disease, 1990